Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair
- PMID: 17537054
- DOI: 10.1111/j.1525-1594.2007.00385.x
Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair
Abstract
Intramyocardial transplantation of skeletal myoblasts augments postinfarction cardiac function. However, poor survival of injected cells limits this therapy. It is hypothesized that implantation of myoblast-based scaffolds would result in greater cell survival. Rat skeletal myoblasts were seeded on highly porous polyurethane (PU) scaffolds (7.5 x 7.5 x 2.0 mm). The effect of several scaffold pretreatments, initial cell densities, and culture periods was tested by DNA-based cell count and viability assessment. Seeded PU scaffolds were implanted on infarcted hearts and immunohistology was performed 4 weeks later. Precoating with laminin allowed the most favorable cell attachment. An initial inoculation with 5 x 10(6) cells followed by a 15-day culture period resulted in optimal myoblast proliferation. Four weeks after their implantation in rats, numerous myoblasts were found throughout the seeded patches although no sign of differentiation could be observed. This myoblast seeding technique on PU allows transfer of a large number of living myoblasts to a damaged myocardium.
Similar articles
-
Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function.Artif Organs. 2010 Feb;34(2):E46-54. doi: 10.1111/j.1525-1594.2009.00937.x. Artif Organs. 2010. PMID: 20420589
-
Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure.J Thorac Cardiovasc Surg. 2006 Jul;132(1):124-31. doi: 10.1016/j.jtcvs.2006.01.052. J Thorac Cardiovasc Surg. 2006. PMID: 16798312
-
Long-term evaluation of myoblast seeded patches implanted on infarcted rat hearts.Artif Organs. 2010 Jun;34(6):E184-92. doi: 10.1111/j.1525-1594.2009.00979.x. Epub 2010 May 7. Artif Organs. 2010. PMID: 20482708
-
Skeletal myoblasts as a therapeutic agent.Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):7-17. doi: 10.1016/j.pcad.2007.02.002. Prog Cardiovasc Dis. 2007. PMID: 17631434 Review.
-
Cell-based therapy for heart failure: skeletal myoblasts.Cell Transplant. 2009;18(7):695-707. doi: 10.3727/096368909X470810. Epub 2009 Apr 6. Cell Transplant. 2009. PMID: 19500482 Review.
Cited by
-
Elastomeric electrospun scaffolds of poly(L-lactide-co-trimethylene carbonate) for myocardial tissue engineering.J Mater Sci Mater Med. 2011 Jul;22(7):1689-99. doi: 10.1007/s10856-011-4351-2. Epub 2011 May 27. J Mater Sci Mater Med. 2011. PMID: 21617996
-
Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies.Cardiol Res Pract. 2012;2012:971614. doi: 10.1155/2012/971614. Epub 2012 Apr 22. Cardiol Res Pract. 2012. PMID: 22577591 Free PMC article.
-
Stem cells and cardiac repair: a critical analysis.J Cardiovasc Transl Res. 2008 Mar;1(1):41-54. doi: 10.1007/s12265-007-9008-7. Epub 2008 Jan 31. J Cardiovasc Transl Res. 2008. PMID: 20559957 Review.
-
Triggerable Degradation of Polyurethanes for Tissue Engineering Applications.ACS Appl Mater Interfaces. 2015 Sep 16;7(36):20377-88. doi: 10.1021/acsami.5b06242. Epub 2015 Sep 3. ACS Appl Mater Interfaces. 2015. PMID: 26312436 Free PMC article.
-
Preconditioning of Human Skeletal Myoblast with Stromal Cell-derived Factor-1α Promotes Cytoprotective Effects against Oxidative and Anoxic Stress.Int J Stem Cells. 2011 Jun;4(1):50-60. doi: 10.15283/ijsc.2011.4.1.50. Int J Stem Cells. 2011. PMID: 24298334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical